tiprankstipranks
Advertisement
Advertisement

RNXT Stock Latest News

RenovoRx completes enrollment in TIGeR-PaC trial
The FlyRenovoRx completes enrollment in TIGeR-PaC trial
2d ago
RNXT
RNXT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RNXT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
RNXT
RenovoRx Highlights TAMP Platform in Upcoming Oncology Webinar
PremiumCompany Announcements
RenovoRx Highlights TAMP Platform in Upcoming Oncology Webinar
9d ago
8K
RNXT
RenovoRx Granted Extended Nasdaq Compliance Period Amid Listing Risk
PremiumCompany Announcements
RenovoRx Granted Extended Nasdaq Compliance Period Amid Listing Risk
1M ago
8K
RNXT
RenovoRx Stockholders Approve Directors and Equity Plan
PremiumCompany Announcements
RenovoRx Stockholders Approve Directors and Equity Plan
1M ago
8K
RNXT
RenovoRx announces FDA Orphan Drug Designation for oxaliplatin
PremiumThe FlyRenovoRx announces FDA Orphan Drug Designation for oxaliplatin
3M ago
RNXT
RenovoRx announces pharmacokinetic data using TAMP platform
Premium
The Fly
RenovoRx announces pharmacokinetic data using TAMP platform
3M ago
RNXT
RenovoRx Earnings Call Signals Commercial Inflection
Premium
Company Announcements
RenovoRx Earnings Call Signals Commercial Inflection
3M ago
RNXT
RenovoRx reports Q1 adjusted EPS (8c), consensus (8c)
PremiumThe Fly
RenovoRx reports Q1 adjusted EPS (8c), consensus (8c)
3M ago
RNXT
RenovoRx sees FY26 revenue $3M-$4M, consensus $3.24M
PremiumThe Fly
RenovoRx sees FY26 revenue $3M-$4M, consensus $3.24M
3M ago
RNXT
RenovoRx files to sell 8.44M shares of common stock for holders
PremiumThe Fly
RenovoRx files to sell 8.44M shares of common stock for holders
4M ago
RNXT
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
PremiumRatings
RenovoRx: Building Commercial Momentum Ahead of TIGeR-PaC Readout Supports Buy-Rated Risk‑Reward Profile
4M ago
RNXT
RenovoRx secures Japanese patent allowance for targeted drug-delivery
PremiumThe FlyRenovoRx secures Japanese patent allowance for targeted drug-delivery
4M ago
RNXT
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
Premium
Company Announcements
RenovoRx Reports 2025 Results and Advances TIGeR-PaC Trial
5M ago
8K
RNXT
RNXT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RNXT Upcoming Earnings Report: What to Expect?
5M ago
RNXT
RenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
PremiumThe Fly
RenovoRx’s TIGeR-PaC Phase III trial surpasses 100 randomized patients
5M ago
RNXT
RenovoRx Raises $10 Million in Oversubscribed Private Placement
PremiumCompany Announcements
RenovoRx Raises $10 Million in Oversubscribed Private Placement
5M ago
8K
RNXT
RenovoRx prices 10.6M shares at 93.8c in private placement
PremiumThe Fly
RenovoRx prices 10.6M shares at 93.8c in private placement
5M ago
RNXT
RenovoRx advances RenovoCath adoption at U.S. cancer centers
PremiumThe Fly
RenovoRx advances RenovoCath adoption at U.S. cancer centers
6M ago
RNXT
RenovoRx announces acceptance of clinical data abstract at 2026 SIR
PremiumThe FlyRenovoRx announces acceptance of clinical data abstract at 2026 SIR
6M ago
RNXT
RenovoRx establishes RenovoCath Medical Advisory Board
Premium
The Fly
RenovoRx establishes RenovoCath Medical Advisory Board
6M ago
RNXT
RenovoRx Appoints Veteran Executive Mark Voll as CFO
Premium
Company Announcements
RenovoRx Appoints Veteran Executive Mark Voll as CFO
6M ago
8K
RNXT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >